Global Dry Eye Syndrome Market Growth 2021-2026
According to this latest study, the 2021 growth of Dry Eye Syndrome will have significant change from previous year. By the most conservative estimates of global Dry Eye Syndrome market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5198.4 million in 2020. Over the next five years the Dry Eye Syndrome market will register a 4.6% CAGR in terms of revenue, the global market size will reach US$ 6226.9 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Syndrome market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Artificial Tears
Anti-inflammatory Drugs
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Retail Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Eye Syndrome Consumption 2016-2026
2.1.2 Dry Eye Syndrome Consumption CAGR by Region
2.2 Dry Eye Syndrome Segment by Type
2.2.1 Artificial Tears
2.2.2 Anti-inflammatory Drugs
2.2.3 Others
2.3 Dry Eye Syndrome Sales by Type
2.3.1 Global Dry Eye Syndrome Sales Market Share by Type (2016-2021)
2.3.2 Global Dry Eye Syndrome Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dry Eye Syndrome Sale Price by Type (2016-2021)
2.4 Dry Eye Syndrome Segment by Distribution Channel
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Dry Eye Syndrome Sales by Distribution Channel
2.5.1 Global Dry Eye Syndrome Sale Market Share by Distribution Channel (2016-2021)
2.5.2 Global Dry Eye Syndrome Revenue and Market Share by Distribution Channel (2016-2021)
2.5.3 Global Dry Eye Syndrome Sale Price by Distribution Channel (2016-2021)
3 Global Dry Eye Syndrome by Company
3.1 Global Dry Eye Syndrome Sales Market Share by Company
3.1.1 Global Dry Eye Syndrome Sales by Company (2019-2021)
3.1.2 Global Dry Eye Syndrome Sales Market Share by Company (2019-2021)
3.2 Global Dry Eye Syndrome Revenue Market Share by Company
3.2.1 Global Dry Eye Syndrome Revenue by Company (2019-2021)
3.2.2 Global Dry Eye Syndrome Revenue Market Share by Company (2019-2021)
3.3 Global Dry Eye Syndrome Sale Price by Company
3.4 Global Manufacturers Dry Eye Syndrome Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Eye Syndrome Product Location Distribution
3.4.2 Players Dry Eye Syndrome Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dry Eye Syndrome by Region
4.1 Global Dry Eye Syndrome by Region
4.1.1 Global Dry Eye Syndrome Sales by Region
4.1.2 Global Dry Eye Syndrome Revenue by Region
4.2 Americas Dry Eye Syndrome Sales Growth
4.3 APAC Dry Eye Syndrome Sales Growth
4.4 Europe Dry Eye Syndrome Sales Growth
4.5 Middle East & Africa Dry Eye Syndrome Sales Growth
5 Americas
5.1 Americas Dry Eye Syndrome Sales by Country
5.1.1 Americas Dry Eye Syndrome Sales by Country (2016-2021)
5.1.2 Americas Dry Eye Syndrome Revenue by Country (2016-2021)
5.2 Americas Dry Eye Syndrome Sales by Type
5.3 Americas Dry Eye Syndrome Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Eye Syndrome Sales by Region
6.1.1 APAC Dry Eye Syndrome Sales by Region (2016-2021)
6.1.2 APAC Dry Eye Syndrome Revenue by Region (2016-2021)
6.2 APAC Dry Eye Syndrome Sales by Type
6.3 APAC Dry Eye Syndrome Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dry Eye Syndrome by Country
7.1.1 Europe Dry Eye Syndrome Sales by Country (2016-2021)
7.1.2 Europe Dry Eye Syndrome Revenue by Country (2016-2021)
7.2 Europe Dry Eye Syndrome Sales by Type
7.3 Europe Dry Eye Syndrome Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dry Eye Syndrome by Country
8.1.1 Middle East & Africa Dry Eye Syndrome Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dry Eye Syndrome Revenue by Country (2016-2021)
8.2 Middle East & Africa Dry Eye Syndrome Sales by Type
8.3 Middle East & Africa Dry Eye Syndrome Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dry Eye Syndrome Distributors
10.3 Dry Eye Syndrome Customer
11 Global Dry Eye Syndrome Market Forecast
11.1 Global Dry Eye Syndrome Forecast by Region
11.1.1 Global Dry Eye Syndrome Forecast by Regions (2021-2026)
11.2.2 Global Dry Eye Syndrome Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Dry Eye Syndrome Forecast by Type
11.7 Global Dry Eye Syndrome Forecast by Distribution Channel
12 Key Players Analysis
12.1 Allergan
12.1.1 Allergan Company Information
12.1.2 Allergan Dry Eye Syndrome Product Offered
12.1.3 Allergan Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Allergan Main Business Overview
12.1.5 Allergan Latest Developments
12.2 Alcon
12.2.1 Alcon Company Information
12.2.2 Alcon Dry Eye Syndrome Product Offered
12.2.3 Alcon Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Alcon Main Business Overview
12.2.5 Alcon Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Dry Eye Syndrome Product Offered
12.3.3 Novartis Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Santen Pharma
12.4.1 Santen Pharma Company Information
12.4.2 Santen Pharma Dry Eye Syndrome Product Offered
12.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Santen Pharma Main Business Overview
12.4.5 Santen Pharma Latest Developments
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Information
12.5.2 Johnson & Johnson Dry Eye Syndrome Product Offered
12.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Johnson & Johnson Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 Bausch & Lomb
12.6.1 Bausch & Lomb Company Information
12.6.2 Bausch & Lomb Dry Eye Syndrome Product Offered
12.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Bausch & Lomb Main Business Overview
12.6.5 Bausch & Lomb Latest Developments
12.7 Thea pharmaceuticals
12.7.1 Thea pharmaceuticals Company Information
12.7.2 Thea pharmaceuticals Dry Eye Syndrome Product Offered
12.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Thea pharmaceuticals Main Business Overview
12.7.5 Thea pharmaceuticals Latest Developments
12.8 URSAPHARM
12.8.1 URSAPHARM Company Information
12.8.2 URSAPHARM Dry Eye Syndrome Product Offered
12.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 URSAPHARM Main Business Overview
12.8.5 URSAPHARM Latest Developments
12.9 SIMILASAN
12.9.1 SIMILASAN Company Information
12.9.2 SIMILASAN Dry Eye Syndrome Product Offered
12.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 SIMILASAN Main Business Overview
12.9.5 SIMILASAN Latest Developments
12.10 Akorn
12.10.1 Akorn Company Information
12.10.2 Akorn Dry Eye Syndrome Product Offered
12.10.3 Akorn Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Akorn Main Business Overview
12.10.5 Akorn Latest Developments
12.11 United Laboratories
12.11.1 United Laboratories Company Information
12.11.2 United Laboratories Dry Eye Syndrome Product Offered
12.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 United Laboratories Main Business Overview
12.11.5 United Laboratories Latest Developments
12.12 Sun Pharmaceutical
12.12.1 Sun Pharmaceutical Company Information
12.12.2 Sun Pharmaceutical Dry Eye Syndrome Product Offered
12.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Sun Pharmaceutical Main Business Overview
12.12.5 Sun Pharmaceutical Latest Developments
12.13 Jianfeng Group
12.13.1 Jianfeng Group Company Information
12.13.2 Jianfeng Group Dry Eye Syndrome Product Offered
12.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Jianfeng Group Main Business Overview
12.13.5 Jianfeng Group Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Dry Eye Syndrome Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Artificial Tears
Table 3. Major Players of Anti-inflammatory Drugs
Table 4. Major Players of Others
Table 5. Global Dry Eye Syndrome Sales by Type (2016-2021) & (M Units)
Table 6. Global Dry Eye Syndrome Sales Market Share by Type (2016-2021)
Table 7. Global Dry Eye Syndrome Revenue by Type (2016-2021) & ($ million)
Table 8. Global Dry Eye Syndrome Revenue Market Share by Type (2016-2021)
Table 9. Global Dry Eye Syndrome Sale Price by Type (2016-2021)
Table 10. Global Dry Eye Syndrome Sales by Distribution Channel (2016-2021) & (M Units)
Table 11. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Table 12. Global Dry Eye Syndrome Value by Distribution Channel (2016-2021)
Table 13. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2016-2021)
Table 14. Global Dry Eye Syndrome Sale Price by Distribution Channel (2016-2021)
Table 15. Global Dry Eye Syndrome Sales by Company (2019-2021) & (M Units)
Table 16. Global Dry Eye Syndrome Sales Market Share by Company (2019-2021)
Table 17. Global Dry Eye Syndrome Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Dry Eye Syndrome Revenue Market Share by Company (2019-2021)
Table 19. Global Dry Eye Syndrome Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Dry Eye Syndrome Producing Area Distribution and Sales Area
Table 21. Players Dry Eye Syndrome Products Offered
Table 22. Dry Eye Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dry Eye Syndrome Sales by Region (2016-2021) (M Units)
Table 26. Global Dry Eye Syndrome Sales Market Share by Region (2016-2021)
Table 27. Global Dry Eye Syndrome Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Dry Eye Syndrome Revenue Market Share by Region (2016-2021)
Table 29. Americas Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 30. Americas Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 31. Americas Dry Eye Syndrome Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 33. Americas Dry Eye Syndrome Sales by Type (2016-2021) & (M Units)
Table 34. Americas Dry Eye Syndrome Sales Market Share by Type (2016-2021)
Table 35. Americas Dry Eye Syndrome Sales by Distribution Channel (2016-2021) & (M Units)
Table 36. Americas Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Table 37. APAC Dry Eye Syndrome Sales by Region (2016-2021) & (M Units)
Table 38. APAC Dry Eye Syndrome Sales Market Share by Region (2016-2021)
Table 39. APAC Dry Eye Syndrome Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Dry Eye Syndrome Revenue Market Share by Region (2016-2021)
Table 41. APAC Dry Eye Syndrome Sales by Type (2016-2021) & (M Units)
Table 42. APAC Dry Eye Syndrome Sales Market Share by Type (2016-2021)
Table 43. APAC Dry Eye Syndrome Sales by Distribution Channel (2016-2021) & (M Units)
Table 44. APAC Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Table 45. Europe Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 46. Europe Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 47. Europe Dry Eye Syndrome Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 49. Europe Dry Eye Syndrome Sales by Type (2016-2021) & (M Units)
Table 50. Europe Dry Eye Syndrome Sales Market Share by Type (2016-2021)
Table 51. Europe Dry Eye Syndrome Sales by Distribution Channel (2016-2021) & (M Units)
Table 52. Europe Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Table 53. Middle East & Africa Dry Eye Syndrome Sales by Country (2016-2021) & (M Units)
Table 54. Middle East & Africa Dry Eye Syndrome Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Dry Eye Syndrome Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Dry Eye Syndrome Sales by Type (2016-2021) & (M Units)
Table 58. Middle East & Africa Dry Eye Syndrome Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Dry Eye Syndrome Sales by Distribution Channel (2016-2021) & (M Units)
Table 60. Middle East & Africa Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Table 61. Key and Potential Regions of Dry Eye Syndrome
Table 62. Key Application and Potential Industries of Dry Eye Syndrome
Table 63. Key Challenges of Dry Eye Syndrome
Table 64. Key Trends of Dry Eye Syndrome
Table 65. Dry Eye Syndrome Distributors List
Table 66. Dry Eye Syndrome Customer List
Table 67. Global Dry Eye Syndrome Sales Forecast by Region (2021-2026) & (M Units)
Table 68. Global Dry Eye Syndrome Consumption Market Forecast by Region
Table 69. Global Dry Eye Syndrome Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Dry Eye Syndrome Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Dry Eye Syndrome Sales Forecast by Country (2021-2026) & (M Units)
Table 72. Americas Dry Eye Syndrome Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Dry Eye Syndrome Sales Forecast by Region (2021-2026) & (M Units)
Table 74. APAC Dry Eye Syndrome Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Dry Eye Syndrome Sales Forecast by Country (2021-2026) & (M Units)
Table 76. Europe Dry Eye Syndrome Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Dry Eye Syndrome Sales Forecast by Country (2021-2026) & (M Units)
Table 78. Middle East & Africa Dry Eye Syndrome Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Dry Eye Syndrome Sales Forecast by Type (2021-2026) & (M Units)
Table 80. Global Dry Eye Syndrome Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Dry Eye Syndrome Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Dry Eye Syndrome Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Dry Eye Syndrome Sales Forecast by Distribution Channel (2021-2026) & (M Units)
Table 84. Global Dry Eye Syndrome Sales Market Share Forecast by Distribution Channel (2021-2026)
Table 85. Global Dry Eye Syndrome Revenue Forecast by Distribution Channel (2021-2026) & ($ Millions)
Table 86. Global Dry Eye Syndrome Revenue Market Share Forecast by Distribution Channel (2021-2026)
Table 87. Allergan Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 88. Allergan Dry Eye Syndrome Product Offered
Table 89. Allergan Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Allergan Main Business
Table 91. Allergan Latest Developments
Table 92. Alcon Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 93. Alcon Dry Eye Syndrome Product Offered
Table 94. Alcon Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Alcon Main Business
Table 96. Alcon Latest Developments
Table 97. Novartis Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Dry Eye Syndrome Product Offered
Table 99. Novartis Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Santen Pharma Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 103. Santen Pharma Dry Eye Syndrome Product Offered
Table 104. Santen Pharma Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Santen Pharma Main Business
Table 106. Santen Pharma Latest Developments
Table 107. Johnson & Johnson Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Dry Eye Syndrome Product Offered
Table 109. Johnson & Johnson Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Bausch & Lomb Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 113. Bausch & Lomb Dry Eye Syndrome Product Offered
Table 114. Bausch & Lomb Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Bausch & Lomb Main Business
Table 116. Bausch & Lomb Latest Developments
Table 117. Thea pharmaceuticals Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 118. Thea pharmaceuticals Dry Eye Syndrome Product Offered
Table 119. Thea pharmaceuticals Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Thea pharmaceuticals Main Business
Table 121. Thea pharmaceuticals Latest Developments
Table 122. URSAPHARM Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 123. URSAPHARM Dry Eye Syndrome Product Offered
Table 124. URSAPHARM Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. URSAPHARM Main Business
Table 126. URSAPHARM Latest Developments
Table 127. SIMILASAN Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 128. SIMILASAN Dry Eye Syndrome Product Offered
Table 129. SIMILASAN Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. SIMILASAN Main Business
Table 131. SIMILASAN Latest Developments
Table 132. Akorn Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 133. Akorn Dry Eye Syndrome Product Offered
Table 134. Akorn Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Akorn Main Business
Table 136. Akorn Latest Developments
Table 137. United Laboratories Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 138. United Laboratories Dry Eye Syndrome Product Offered
Table 139. United Laboratories Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. United Laboratories Main Business
Table 141. United Laboratories Latest Developments
Table 142. Sun Pharmaceutical Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 143. Sun Pharmaceutical Dry Eye Syndrome Product Offered
Table 144. Sun Pharmaceutical Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Sun Pharmaceutical Main Business
Table 146. Sun Pharmaceutical Latest Developments
Table 147. Jianfeng Group Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 148. Jianfeng Group Dry Eye Syndrome Product Offered
Table 149. Jianfeng Group Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. Jianfeng Group Main Business
Table 151. Jianfeng Group Latest Developments
List of Figures
Figure 1. Picture of Dry Eye Syndrome
Figure 2. Dry Eye Syndrome Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Eye Syndrome Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Dry Eye Syndrome Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dry Eye Syndrome Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Artificial Tears
Figure 10. Product Picture of Anti-inflammatory Drugs
Figure 11. Product Picture of Others
Figure 12. Global Dry Eye Syndrome Sales Market Share by Type in 2020
Figure 13. Global Dry Eye Syndrome Revenue Market Share by Type (2016-2021)
Figure 14. Dry Eye Syndrome Consumed in Hospital
Figure 15. Global Dry Eye Syndrome Market: Hospital (2016-2021) & (M Units)
Figure 16. Dry Eye Syndrome Consumed in Retail Pharmacy
Figure 17. Global Dry Eye Syndrome Market: Retail Pharmacy (2016-2021) & (M Units)
Figure 18. Dry Eye Syndrome Consumed in Others
Figure 19. Global Dry Eye Syndrome Market: Others (2016-2021) & (M Units)
Figure 20. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2016-2021)
Figure 21. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel in 2020
Figure 22. Dry Eye Syndrome Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Dry Eye Syndrome Revenue Market Share by Company in 2020
Figure 24. Global Dry Eye Syndrome Sales Market Share by Regions (2016-2021)
Figure 25. Global Dry Eye Syndrome Revenue Market Share by Region in 2020
Figure 26. Americas Dry Eye Syndrome Sales 2016-2021 (M Units)
Figure 27. Americas Dry Eye Syndrome Revenue 2016-2021 ($ Millions)
Figure 28. APAC Dry Eye Syndrome Sales 2016-2021 (M Units)
Figure 29. APAC Dry Eye Syndrome Revenue 2016-2021 ($ Millions)
Figure 30. Europe Dry Eye Syndrome Sales 2016-2021 (M Units)
Figure 31. Europe Dry Eye Syndrome Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Dry Eye Syndrome Sales 2016-2021 (M Units)
Figure 33. Middle East & Africa Dry Eye Syndrome Revenue 2016-2021 ($ Millions)
Figure 34. Americas Dry Eye Syndrome Sales Market Share by Country in 2020
Figure 35. Americas Dry Eye Syndrome Revenue Market Share by Country in 2020
Figure 36. Americas Dry Eye Syndrome Sales Market Share by Type in 2020
Figure 37. Americas Dry Eye Syndrome Sales Market Share by Distribution Channel in 2020
Figure 38. United States Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Dry Eye Syndrome Sales Market Share by Region in 2020
Figure 43. APAC Dry Eye Syndrome Revenue Market Share by Regions in 2020
Figure 44. APAC Dry Eye Syndrome Sales Market Share by Type in 2020
Figure 45. APAC Dry Eye Syndrome Sales Market Share by Distribution Channel in 2020
Figure 46. China Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Dry Eye Syndrome Sales Market Share by Country in 2020
Figure 53. Europe Dry Eye Syndrome Revenue Market Share by Country in 2020
Figure 54. Europe Dry Eye Syndrome Sales Market Share by Type in 2020
Figure 55. Europe Dry Eye Syndrome Sales Market Share by Distribution Channel in 2020
Figure 56. Germany Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Dry Eye Syndrome Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Dry Eye Syndrome Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Dry Eye Syndrome Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Dry Eye Syndrome Sales Market Share by Distribution Channel in 2020
Figure 65. Egypt Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Dry Eye Syndrome Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
